BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 22339650)

  • 1. Biology and significance of the JAK/STAT signalling pathways.
    Kiu H; Nicholson SE
    Growth Factors; 2012 Apr; 30(2):88-106. PubMed ID: 22339650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK/STAT in leukemia: a clinical update.
    Liang D; Wang Q; Zhang W; Tang H; Song C; Yan Z; Liang Y; Wang H
    Mol Cancer; 2024 Jan; 23(1):25. PubMed ID: 38273387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia.
    Lee HJ; Daver N; Kantarjian HM; Verstovsek S; Ravandi F
    Clin Cancer Res; 2013 Jan; 19(2):327-35. PubMed ID: 23209034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
    Kleppe M; Kwak M; Koppikar P; Riester M; Keller M; Bastian L; Hricik T; Bhagwat N; McKenney AS; Papalexi E; Abdel-Wahab O; Rampal R; Marubayashi S; Chen JJ; Romanet V; Fridman JS; Bromberg J; Teruya-Feldstein J; Murakami M; Radimerski T; Michor F; Fan R; Levine RL
    Cancer Discov; 2015 Mar; 5(3):316-31. PubMed ID: 25572172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tools and methods for studying the Drosophila JAK/STAT pathway.
    Chen Q; Giedt M; Tang L; Harrison DA
    Methods; 2014 Jun; 68(1):160-72. PubMed ID: 24685392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
    Montero P; Milara J; Roger I; Cortijo J
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosing JAK/STAT links to cell adhesion and cell polarity.
    Hombría JC; Sotillos S
    Semin Cell Dev Biol; 2008 Aug; 19(4):370-8. PubMed ID: 18590829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targeting of the Jak/STAT pathway.
    Aittomäki S; Pesu M
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):18-23. PubMed ID: 24164900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining for JAK-STAT mutations in cancer.
    Constantinescu SN; Girardot M; Pecquet C
    Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant calreticulin in myeloproliferative neoplasms.
    How J; Hobbs GS; Mullally A
    Blood; 2019 Dec; 134(25):2242-2248. PubMed ID: 31562135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
    Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
    Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.
    Venugopal S; Bar-Natan M; Mascarenhas JO
    Blood Rev; 2020 Mar; 40():100634. PubMed ID: 31677846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
    Rampal R; Al-Shahrour F; Abdel-Wahab O; Patel JP; Brunel JP; Mermel CH; Bass AJ; Pretz J; Ahn J; Hricik T; Kilpivaara O; Wadleigh M; Busque L; Gilliland DG; Golub TR; Ebert BL; Levine RL
    Blood; 2014 May; 123(22):e123-33. PubMed ID: 24740812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the JAK/STAT signaling through erythropoietin receptor and thrombopoietin receptor using a systems approach.
    Won HH; Park I; Lee E; Kim JW; Lee D
    BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S53. PubMed ID: 19208156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK/STAT signaling pathway: from bench to clinic.
    Hu X; Li J; Fu M; Zhao X; Wang W
    Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
    Manea SA; Manea A; Heltianu C
    Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
    Durham GA; Williams JJL; Nasim MT; Palmer TM
    Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SnapShot: Jak-STAT Signaling II.
    Villarino AV; Gadina M; O'Shea JJ; Kanno Y
    Cell; 2020 Jun; 181(7):1696-1696.e1. PubMed ID: 32589961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
    Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
    Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.